References

1. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.

2. Arnold EP, Burgio K, Diokno AC, et al. Epidemiology and natural history of urinary incontinence (UI). In: Abrams P, Khoury S, Wein AJ, eds. Incontinence. Plymouth, UK: Plymbridge Distributors; 1999:199-226.

3. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes, Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003;188:S77-S88.

4. Rovner ES, Wyman J, Lackner T, Guay DRP. Urinary Incontinence. In: DiPiro J, Talbert R, Hayes P, Yee G, Matzke G, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. New York: McGraw-Hill, 2008:1399-1415.

5. Groutz A, Gordon D, Keidar R, et al. Stress urinary incontinence: Prevalence among nulliparous compared with primiparous and grand multiparous premenopausal women. Neurourol Urodyn 1999;18:419-425.

Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence. Second International Consultation on Incontinence. 2nd ed. Plymouth, UK: Health Publications Ltd, 2002.

Kafri R, Langer R, Dvir Z, et al. Rehabilitation vs drug therapy for urge urinary incontinence: Short-term outcome. Int Urogynecol J 2007;18:407-411.

Kafri R, Shames J, Raz M, et al. Rehabilitation versus drug therapy for urge urinary incontinence: Long-term outcomes. Int Urogynecol J Pelvic Floor Dyfunet 2008;19:47-52.

Shamliyan TA, Kane RL, Wyman J, et al. Systematic review: Randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008;148:459-473.

Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis. Eur Urol 2005;48:5-26.

Novara G, Balfano A, Secco S, et al. A systematic review and meta-analysis of randomized controlled trials with antiimmunocarcinic drugs for overactive bladder. Eur Urol 2008;54:740-763.

Hofner K, Burkart M, Jacob G, et al. Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol 2007;25:627-633.

Ortho-McNeil Pharmaceutical. Ditropan XL (oxybutynin) package insert. Raritan, NJ: Ortho-McNeil Pharmaceutical, 2008.

Pharmacia & Upjohn. Detrol and Detrol LA (tolterodine) package inserts. New York: Pharmacia & Upjohn, 2005.

Watson Pharma. Oxytrol (oxybutynin transdermal system) package insert. Corona, CA: Watson Pharma, 2003.

Odyssey/Indevus Pharmaceuticals. Sanctura (trospium chloride) package insert. East Hanover, NJ/Lexington, MA: Odyssey/Indevus Pharmaceuticals, 2004.

Astellas Pharma U.S. VESIcare (solifenacin) package insert. Deerfield, IL: Astellas Pharma U.S., 2004.

Novartis. Enablex (darifenacin) package insert. East Hanover, NJ: Novartis, 2004.

Guay DRP. Drug forecast: Solifenacin (VESIcare): An investigational anticholinergic for overactive bladder. Consult Pharm 2004;19:437-444.

Guay DRP. Trospium chloride: An update on a quaternary anticholinergic for treatment of urge urinary incontinence. Ther Clin Risk Manag 2005;1:157-166.

Guay DRP. Darifenacin: Another antimuscarinic for overactive bladder. Consult Pharm 2005;20:424-431.

Sink KM, Thomas J 3rd, Xu H, et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: Long-term functional and cognitive outcomes. J Am Geriatr Soc 2008;56:847-853.

Hashim H, Abrams P. Novel uses for antidiuresis. Int J Clin Pract 2007;(Suppl 155):32-36.

Steers WD, Herschorn S, Kreder KJ, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int 2007;100:337-345.

Peyromaure M, Ravery V, Boccon-Gibod L. The management of stress urinary incontinence after radical prostatectomy. BJU Int 2002;90:155-161.

Filcamo MT, LiMarzi V, DelPopolo G, et al. Pharmacologic treatment in postpro-statectomy stress urinary incontinence. Eur Urol 2007;51:1559-1564.

Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;343:1826-1832.

Owens RG, Karram MM. Comparative tolerability of drug therapies used to treat incontinence and enuresis. Drug Saf 1998;2:123-139.

Guay DRP. Duloxetine. The first therapy licensed for stress urinary incontinence. Am J Geriatr Pharmacother 2005;3:25-38.

Fraser MO, Chancellor MB. Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int 2003;91:743-748.

Burgard EC, Fraser MO, Thor KB. Serotonergic modulation of bladder afferent pathways. Urology 2003;62(Suppl 1):10-15.

Eli Lilly & Co. Cymbalta (duloxetine) package insert. Indianapolis, IN: Eli Lilly & Co, 2004.

Filocamo MT, LiMarzi V, Del Popolo G, et al. Pharmacologic treatment in post-prostatectomy stress urinary incontinence. Eur Urol 2007; 51: 1559-1564.

Duckett JR, Vella M, Kavalakuntla G, et al. Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 2007;114:543-547.

35. Fritz G, Rockney R, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with enuresis. J Am Acad Child Adolesc Psychiatry 2004;43:1540-1550.

36. Hjalmar K, Arnold T, Bower W, et al. Nocturnal enuresis: An international evidence based management strategy. J Urol 2004;171(6 pt 2):2545-2561.

37. Rittig S, Schaumberg HL, Siggaard C, et al. The circadian effect in plasma vaso-pressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis. J Urol 2008;179:2389-2395.

38. Blum NJ. Nocturnal enuresis: Behavioral treatments. Urol Clin North Am 2004;31:499-507.

39. Bower WF, Diao M, Tang JL, Yeung CK. Acupuncture for nocturnal enuresis in children: A systematic review and exploration of rationale. Neurourol Urodyn 2005;24:267-272.

40. Glazener CM, Evans JH, Peto RE. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database Syst Rev 2003;(4):CD002238.

41. Aventis Pharmaceuticals. DDAVP (desmopressin) package inserts. Bridgewater, NJ: Aventis Pharmaceuticals, 2002.

42. Glazener CM, Evans JH. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 2002;(3):CD002112.

43. Raes A, Dehoorne J, Van Laecke E, et al. Partial response to intranasal desmo-pressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights. J Urol 2007;178:1048-1052.

44. DeGuchtenaere A, Vande Walle C, Van Sintjan P, et al. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning. J Urol 2007;178:2635-2639.

45. Muller D, Roehr CC, Eggert P. Comparative tolerability of drug treatment for nocturnal enuresis in children. Drug Saf 2004;27:717-727.

46. Glazener CM, Evans JH, Peto RE. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2003;(3):CD002117.

47. Glazener CM, Evans JH. Simple behavioural and physical interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2004;(2):CD003637.

48. Glazener CM, Evans JH, Peto RE. Complex behavioural and educational interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2004;(1):CD004668.

49. Reiner WG. Pharmacotherapy in the management of voiding and storage disorders, including enuresis and encopresis. J Am Acad Child Adolesc Psychiatry 2008;47:491-498.

50. Neveus T. The dilemmas of refractory nocturnal enuresis. J Urol 2008;179:817-818.

51. Neveus T, Tullus K. Tolterodine and imipramine in refractory enuresis: A placebo-controlled crossover study. Pediatr Nephrol 2008;23:263-267.

SECTION 10 IMMUNOLOGIC DISORDERS

54 Allergic and Pseudoallergic Drug Reactions

J. Russell May and Philip H. Smith

LEARNING OBJECTIVES

99 Ways To Stop Bedwetting

99 Ways To Stop Bedwetting

53 Minutes From Now, You'll Know Exactly How To Stop Your Child From Wetting The Bed...Without Drama Or Discipline. It's one of the hardest problems families face and can be very tough on a child's self esteem. When one of your children is a bed wetter, it can be a very sensitive topic. Even though it's a normal part of growing up, siblings can still give them a hard time.

Get My Free Ebook


Post a comment